If you would like to download this document, please click here

 

 

 

Duncan R Harriss DM FRCS(Urol)

Consultant Urological Surgeon

Duncan Harriss Consulting Ltd

urologymedicolegal@gmail.com

 

Personal Details

Name Duncan Ross HARRISS

Date of birth 7 February 1963

Correspondence Address

BMI Park Hospital

Sherwood Lodge Drive

Burnstump Country Park

Arnold

Nottingham

NG5 8RX

Mobile Telephone 07811 216758

Email duncanharriss@googlemail.com

 

Medico-legal Secretary

Mrs Bev Pugh

BMI Park Hospital

Sherwood Lodge Drive

Burnstump Country Park

Arnold

Nottingham

NG5 8RX

Telephone 07977 027431

Email urologymedicolegal@gmail.com

 

Registration Details and Professional Indemnity Insurance

General Medical Council registration number 3125380

Revalidated March 2013

Urology Specialist Register

CCST awarded 18th April 1997

Professional Indemnity:

Premium Medical Protection 159373

Current Appointment

Consultant Urological Surgeon

Nottingham University Hospitals NHS Trust

Appointed 1 August 1997

 

Medical Education

University Guys Hospital Medical School 1981–1986

Postgraduate Nottingham University Medical School 1992-1994

Medical Qualifications

1986 MBBS (London)

1990 FRCS(Eng)

1994 DM (Nottingham)

1996 FRCS(Urol)

DM thesis title

“Intracellular second messenger signalling pathways in human detrusor cultured smooth muscle cells.”

Awarded Doctor of Medicine (University of Nottingham)

December 1994

 

Societies/Fellowships/Examiner

Royal College of Surgeons of England (fellow)

British Association of Urological Surgeons (BAUS full member)

BAUS Section of Oncology (full member)

Nottingham Medical-Chirurgical Society (ex officio treasurer)

Examiner for FRCS(Urol) 2006-2011

Moynihan Chirurgical Club member

Immediate previous appointments

Senior Registrar in Urology

Sept 94 – Jul 97 Nottingham/Derby Rotation

Travelling Fellowship

Oct – Nov 1996Urological Oncology and Paediatric Urology

Denver University Hospital, Colorado, USA

Ethicon Foundation Travelling Scholarship

Postgraduate Research Joint Superviser to:

Mr CB Chua (DM awarded 1999)

Desensitisation of Muscarinic and Histamine Receptors in Human Detrusor Smooth Muscle

Mr G Mann

Intracellular Second Messenger Pathways in Human Detrusor

Mr MAA Hamid (BUFoundation Scholar - DM awarded 2005)

Proliferation Mechanisms in Human Prostatic Smooth Muscle

Mr A Myatt (PhD awarded 2006)

Prostatic smooth muscle cell culture – protein kinase-activated receptor physiology

Committee Appointments Held

Committee on Ethics in Medicine (1994-1998)

Nottingham City Hospital

Local Negotiating Committee (1995-1996)

Derby City Hospital

Trent Regional Educational Sub-Committee in Urology (1997-2002)

Nottingham City Hospital Trust Training Committee (1997-2003)

Urology Forum (1997-2003)

Theatre Users Group (1997-2001)

Nottingham City Hospital

Surgical Oncology Group (1997-2001)

Nottingham City Hospital

Urological Oncology MDT Chair (1999-2002)

Nottingham City Hospital

Medical Advisory Committee (1999-2004)

Nottingham Nuffield Hospital

Council Member (Honorary Treasurer, 2001-2004)

Nottingham Medico-Chirurgical Society

Von Hippel Lindau MDT Chair (2002-2004)

Nottingham City Hospital

MCQ writing committee FRCS(Urol) (2002-2006)

Royal College of Surgeons Intercollegiate Board

NHS cancer dataset piloting committee (2002-2004)

NHS information authority (BAUS representative)

Nottingham Urology Centre: New Build Project Director (2004-2005)

Court of Examiners FRCS(Urol) (2006-2011)

Royal College of Surgeons Intercollegiate Board

Medical Advisory Committee (2007-)

BMI Park Hospital

Management Appointments Held

Lead Clinician for Urological Cancer (1997-2002)

Nottingham Cancer Centre

Programme Director Mid-Trent Urology Specialist Registrar Training Scheme (1997-2002)

Lead Clinician for Cancer Collaborative Project (2001)

Nottingham Cancer Centre

Clinical Director in Urology (2002-2007)

Medico-legal expertise

Uro-oncology

Prostate cancer

Bladder cancer

Kidney cancer

Testis cancer

Penis cancer

Urinary stone disease

-ESWL

-rigid and flexible ureteroscopy

-holmium lasertripsy

-percutaneous nephrolithotomy

Lower Urinary Tract Function

-prostate disease

-bladder dysfunction

-incontinence

-injury to bladder or ureter

Sexual function

-erectile dysfunction

-Peyronie’s disease

Medicolegal Work

-personal injury

-medical negligence

-adviser to GMC Fitness to Practice panel

I currently provide in excess of 125 medical reports per year (70% Claimant/30% Defendant)

I attended the BAUS approved MPS training course for medico-legal instructions May 2013

Publications

Papers

Harriss DR and Graham TR.  Management of Intercostal Drains (Review). British Journal of Hospital Medicine 1991; 45: 383-6

Harriss DR, Galea M, Graham TR and Salama FD.  Para-oesophageal hernias: When to Operate?  Annals of the Royal College of Surgeons (Ed.) 1992; 37: 97-98

Harriss DR and Graham TR.  Surgical Stapling Devices (Review).  Surgery 1992; 10: 1 - 8

Harriss DR and Blake JRS.  A computerised audit for colorectal cancer. Annals of the Royal College of Surgeons (Eng.) 1993; 75: 268-271

Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery bypass surgery: a randomised, double blind, placebo-controlled trial. British Heart Journal 1993, 70: 56-60

James MJ, Harriss DR, Birmingham AT and Hill SJ.  Significance of atropine concentration for the incidence of tetrodotoxin-resistant relaxations of human detrusor strips.  British Journal of Clinical Pharmacology 1993; 36: 480-481

Harriss DR, Beckingham IJ, Lemberger RJ and Lawrence WT.  Long term results of intermittent low-friction self-catheterisation in 101 patients with recurrent urethral strictures.  British Journal of Urology 1994; 74: 790-792

Harriss DR, Marsh KA, Birmingham AT and Hill SJ.  Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells.  Journal of Urology 1995; 154: 1241-1245

Harriss DR.  Smooth muscle cell culture: A new approach to the study of human

detrusor physiology and pathophysiology (Review).  British Journal of Urology 1995; 75: Suppl. 1, 18-26

Harriss DR and Savill J. Apoptosis and the prostate (Review).  British Journal of Urology 1995; 75: Suppl. 1, 27-33

James MJ, Harriss DR, Ceccherini AF, Manhire A and Bates CP.  A urodynamic study of laser ablation of the prostate and a comparison of techniques.  British Journal of Urology 1995; 76: 179-183

Marsh KA, Harriss DR and Hill SJ.  Desensitisation of muscarinic receptor-coupled inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells.  Journal of Urology 1996; 155: 1439-1443

Harriss DR, Iacovou JW and Lemberger RJ.  Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence.  British Journal of Urology 1996; 78: 722-728

Henley M, Harriss DR and Bishop MC.  Cystitis associated with tiaprofenic acid (Surgam); a survey of British and Irish urologists. British Journal of Urology 1997; 79: 585-587

Harriss DR.  Specialty Focus: Urology. Surgery (Scalpel) 1998; 7: 1-2

Harriss DR.  Management of Urethral Stricture. Trends in Gynaecology & Sexual Health 1999; 4: 31-35

Devarajan R, Jaganathan RS, Harriss DR, Chua CB and Bishop MC.  Combined transurethral prostatectomy and inguinal hernia repair: a retrospective audit and literature review.  BJU International 1999; 84: 637-639

AA Rahman, A Lophatananon, SS Brown, D Harriss, J Anderson, T Parker, D Easton, Z Kote-Jarai, R Pocock, D Dearnaley, M Guy, L O’Brien, RA Wilkinson, AL Hall, E Sawyer, E Page, J-F Liu, The UK Genetic Prostate Cancer Study Collaborators, British Association of Urological Surgeons’ Section of Oncology, RA Eeles and K Muir.  Hand pattern indicates prostate cancer risk.  Br J Cancer 2010; 1-3

 

Published Abstracts

Harriss DR, Marsh KA, Birmingham AT and Hill SJ.  Muscarinic M3 receptor mediated phosphoinositide hydrolysis in human cultured detrusor smooth muscle cells.  British Journal of Pharmacology 1994; 112: 458P

Harriss DR, Bates CP and Marsh KA.  Agonist-induced changes in intracellular calcium ion concentration of single human detrusor cells. Journal of Urology 1994; 151: 446A

Wason AM, Harriss DR, McMillan PC, Bishop MC and Ansell ID.  Transrectal ultrasound in follow-up of patients receiving radical radiotherapy for prostate cancer.  British Journal of Radiology 1994; 67: 85

Henley M, Harriss DR and Bishop MC.  Cystitis associated with tiaprofenic acid (Surgam); a survey of British and Irish urologists. British Journal of Urology  1996; 77 (Suppl.  1): 13

Chua CB, Harriss DR, Marsh KA and Bates CP.  Histamine-induced inositol phosphate responses in detrusor smooth muscle cells. Journal of Urology 1997; 157 (Suppl): 173

Chua CB, Harriss DR, Marsh KA and Hill SJ.  Desensitisation of muscarinic and histamine receptor responses in human detrusor smooth muscle.  British Journal of Urology 1997; 80: 163

Chua CB, Harriss DR, Marsh KA and Hill SJ.  Detrusor instability - is it due to defective receptor desensitisation?  British Journal of Urology 1997; 79 (Suppl. 4): 58

Chua CB, Harriss DR, Marsh KA.  Hill SJ and Bates CP.  Effect of darifenacin on muscarinic responses in normal and unstable detrusor smooth muscle cells. Neurourol.  Urodyn. 1997; 16: 355-6

Chua CB, Harriss DR, Marsh KA, Hill SJ and Bates CP.  Muscarinic M3 receptor desensitisation in normal and unstable detrusors.  Neurourol. Urodyn. 1997; 16: 357

Chua CB, Harriss DR, Marsh KA, Hill SJ & Bates CP. Histamine-induced inositol phosphate response in detrusor smooth muscle cells. Journal of Urology 1997; 157 suppl: 173

Chua CB, Harriss DR, Marsh KA & Hill SJ. Rapid desensitization of muscarinic M3 but not histamine H1 receptors in primary human detrusor smooth muscle cells. British Journal of Pharmacology 1997; 122 suppl: 52P

Chua CB, Mann GS, Harriss DR and Hill SJ. Desensitization of muscarinic M3- and histamine H1-receptor mediated calcium responses in human detrusor smooth muscle. British Journal of Urology 1998; 82: 158-159

Grant LA, Cole O and Harriss DR.  Audit of the success of the two week cancer referral scheme.  BJU Int  2001 88  Suppl 1, 17

 

Letters and Case Reports

Harriss DR and Beechey-Newman N. Torsion of an undescended testis (case report). British Journal of Urology 1990; 66: 552

Harriss DR and Graham TR. Management of Intercostal Drains (Letter). British Medical Journal 1990; 301: 1165

Harriss DR and Graham TR.  Intercostal Drain Management: A Matter for Debate (Letter). British Journal of Hospital Medicine 1991; 46: 267

 

Papers presented

Local meetings

Harriss DR, Grogono JL.  Results of wide excision in early breast cancer.

Thames Valley Surgeons.  Wycombe.  April 1989

Harriss DR, Wason A-M, Ansell ID, MacMillan P, Bishop MC. 10 years of radical radiotherapy for prostate cancer.  Trent Urology Group.  Mansfield, Nottinghamshire.  March 1993

Harriss DR, James MJ, Ceccherini AF, Manhire A, Bates CP.  Laser prostatectomy - the first year results.  Trent Urology Group.  Nottingham.  November 1994

Harriss DR, Beckingham IJ, Lemberger RJ and Lawrence WT.  Long term results of intermittent low friction self-catheterisation in 101 patients with urethral strictures.  Trent Urology Group.  Nottingham.  November 1994

Harriss DR and Beck RO.  Ureteroscopic holmium lasertripsy - technique

and complications.  Derby holmium laser day.  September 1996.

Harriss DR.  PSA levels after TURP.  Trent Urology Group.  April 1997.

 

National meetings

Harriss DR, Beckingham IJ, Lemberger RJ and Lawrence WT, Long term results of intermittent low friction self-catheterisation in 101 patients with urethral strictures.  BAUS.  Harrogate.  June 1993.

Harriss DR, Marsh KA, Bates CP, Birmingham AT, Hill SJ.

Agonist-induced changes in intracellular calcium ion concentration and accumulation of inositol phosphates in human cultured detrusor cells.  Urological Research Society.  Guy's Hospital, London.  Jan 1994. (Prize for Best Scientific Paper)

Harriss DR, Marsh KA, Birmingham AT, Hill SJ.  Muscarinic M3 receptor-mediated phosphoinositide hydrolysis in human cultured detrusor smooth muscle cells.  British Pharmacological Society.  Victoria University of Manchester.  April 1994

Harriss DR. New insights in cellular physiology.

The Urological Club.  Southwell, Notts.  May 1994

Harriss DR, Wason A-M, Ansell ID, McMillan P, Sokal M, Bishop MC.  PSA and TRUS in the evaluation of patients with cancer of the prostate treated with radical radiotherapy.  BAUS.  Birmingham.  June 1994.

Harriss.DR, Marsh KA, Birmingham AT, Hill SJ.  Muscarinic receptor expression in human cultured detrusor smooth muscle cells..  Guy's Hospital.  January 1995

Harriss DR, Lemberger RJ, Bates CP and Bishop MC.  Cystitis in patients

taking tiaprofenic acid (Surgam).  BAUS.  Brighton.  June 1995

Harriss DR, James MJ, Ceccherini AF, Manhire A, Bates CP.  A urodynamic study of laser prostatectomy - the first year results.  BAUS.  Brighton.  June 1995

Harriss DR.  Medicolegal aspects of urology.  AVMA annual convention. Leeds.  June 2013

 

International meetings

Harriss DR, Hill SJ, Birmingham AT and Bates CP.  Characterisation of nitric oxide-mediated relaxation of human detrusor strips in vitro.  Read by title at the International Continence Society.  Rome.  September 1993.

Harriss DR, Bates CP, Marsh KA.  Agonist-induced changes in intracellular calcium ion concentration of single human detrusor cells.  Annual Meeting of American Urological Association.  San Francisco, California, USA.  May 1994

Harriss DR, Chua CB, Marsh KA.  Muscarinic responses in normal and chronic retention detrusor smooth muscle cells.  International Continence Society.  Athens.  August 1996

Harriss DR.  Laparoscopic radical prostatectomy – indications and outcomes.  IRCAD, Strasbourg. May 2013

 

Other communications

Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone Prophylaxis for Supraventricular Tachyarrhythrnias after Coronary Artery Surgery: A Randomised, Double-Blind, Placebo-Controlled Trial.  The 1st World Congress of the International Society of Cardiothoracic Surgeons.  Chiang Mai, Thailand. 30th Sept - 4th Oct 1991.

Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone Prophylaxis for Supraventricular Tachyarrhythrnias after Coronary Artery Surgery: A Randomised, Double-Blind, Placebo-Controlled Trial.  Cardiac Research Club.  York. 30th November 1991.

Wason A-M, Harriss DR, Ansell ID, Bishop MC, MacMillan P. Transrectal ultrasound and PSA in the evaluation of disease-free status after radical radiotherapy for cancer of the prostate.  Annual Meeting of UK Association of Sonographers- Nottingham. 24th September 1993.

Wason AM, Harriss DR, McMillan PC, Bishop MC, Ansell ID.  Transrectal ultrasound in follow-up of patients receiving radical radiotherapy for prostate cancer.  Radiology and Oncology '94, Annual Meeting of the British Institute of Radiology.  Harrogate. 24th May 1994.

Usman F, Harriss DR, Lemberger RJ and Iacovou J. Macroplastique for genuine stress incontinence.  Trent Urology Group.  Nottingham. 9th November 1994

Marsh KA, Harriss DR, Birmingham AT and Hill SJ.  Muscarinic receptor desensitisation in human detrusor cultured smooth muscle cells.  British Pharmacological Society.  Brighton. 14th December 1994

Marsh KA, Harriss DR, Birmingham AT and Hill SJ.  Desensitisation of the carbachol-induced phosphoinositide response in human cultured detrusor smooth muscle cells.  Urological Research Society.  Guy's Hospital, London. 6th January 1995

Henley M, Harriss DR and Bishop MC.  Cystitis associated with tiaprofenic acid (Surgam); a survey of British and Irish Urologists.  BAUS, Edinburgh, 27th June 1996

Chua CB, Harriss DR, Marsh KA.  Histamine-induced inositol phosphate responses in detrusor smooth muscle cells.  International Continence Society.  Athens.  August 1996

Chua CB, Harriss DR, Marsh KA and Hill SJ.  Desensitisation of muscarinic and histamine receptor responses in human detrusor smooth muscle.  Urological Research Society.  Guys Hospital.  January l997

Chua CB, Harriss DR, Marsh KA and Bates CP.  Histamine-induced inositol phosphate responses in detrusor smooth muscle cells.  American Urological Association.  New Orleans.  April 1997

Chua CB, Harriss DR, Marsh KA and Hill SJ.  Detrusor instability - is it due to defective receptor desensitisation?  BAUS, Bournemouth.  June 1997

Chua CB, Harriss DR, Marsh KA, Hill SJ and Bates CP.  Effect of darifenacin on muscarinic responses in normal and unstable detrusor smooth muscle cells.  International Continence Society, Japan, 1997

Chua CB, Harriss DR, Marsh KA, Hill SJ and Bates CP.  Muscarinic M3 receptor desensitisation in normal and unstable detrusors.  International Continence Society, Yokohama, Japan, 1997

Chua CB, Harriss DR, Marsh KA & Hill SJ. Rapid desensitization of muscarinic M3 but not histamine H1 receptors in primary human detrusor smooth muscle cells. British Pharmacological Society, Summer Meeting, Bristol, UK, 1997

Chua CB, Mann GS, Harriss DR and Hill SJ. Desensitization of muscarinic M3- and histamine H1-receptor mediated calcium responses in human detrusor smooth muscle. Urological Research Society, Guy’s Hospital, London, 1998

Mann GS, Hill SJ and Harriss DR.  Intracellular calcium responses in cultured human detrusor smooth muscle:  preliminary evidence of receptor interaction. Urological Research Society, London. January 2000

Grant LA, Cole O and Harriss DR.  Audit of the two week urological cancer referral scheme.  BAUS, Dublin  June 2001

Mann GS, Bishop MC and Harriss DR.  Ureteric replacement strategies. BAUS, Dublin  June 2001

Lophatananon A, Muir KR, Armstrong S, Harriss DR and Anderson JB.  Height and risk of prostate cancer:  a case-control study using BPH and latent prostate cancer as ‘controls’.  British Prostate Group 2002

 

Personal Statement

Experience and qualifications

My name is Duncan Ross Harriss.  I trained in medicine at Guy’s Hospital Medical School, London qualifying (MBBS) in June 1986.  I am a Fellow of the Royal College of Surgeons (FRCS 1990) and I have passed the sub speciality examination in urology (FRCS Urol 1996).  My research thesis investigated the intracellular mechanisms involved in normal bladder function (DM Nottingham 1994).  My clinical research interests have included the epidemiology of prostate cancer and the treatment of bladder, urethral and prostatic disease.  I was appointed Consultant Urological Surgeon at the Nottingham Urology Centre, City Campus, Nottingham University Hospitals NHS Trust on the 1st August 1997.  My sub-specialist practice is pelvic surgical oncology including the diagnosis and treatment of kidney, prostate, bladder, testicular and penile cancer.  Both my NHS and private practice include surgery for investigation and surgery for general urological disease (stones, prostate disease, erectile dysfunction and urinary incontinence).  I have extensive medicolegal experience in claims related to gynaecological injury of the urinary tract and cauda equina syndrome.

I was Urology Clinical Director between 2000 and 2005.  I was examiner for the subspecialty examination in urology for the Intercollegiate Speciality Board of the Royal College of Surgeons in England, Edinburgh, Glasgow and Dublin between 2006 and 2011.  I am urology advisor to the Fitness to Practice panel of the General Medical Council.  I am a Nottingham member of the Moynihan Chirurgical Club.  I have been writing medical reports since 1997 (currently 200 per year) receiving instructions in cases of clinical negligence (80% Claimant and 20% Defendant) and personal injury.  I am familiar with the Civil Procedure Rules.

I am an associate member of the Academy of Experts and I have been included in the medical expert database of The Action Against Medical Accidents (AvMA) charity.  I am registered as a member of Expert Witness.  I have completed the British Association of Urological Surgeons (BAUS) sponsored Expert Witness Certificate by the Medical Protection Society.  I am a Tier One Expert for the Association of Personal Injury Lawyers (APIL).

 

TESTIMONIALS

“Mr Harriss provided clear “user-friendly” explanations of the relevant anatomy, the surgery, the likely mechanism of the injury and the consequences. He is a thoughtful expert who reflects upon his opinion appropriately and whilst firm in his views, is not unduly robust. A Court is likely to find his views persuasive.”

Fiona Patterson QC 

“I can highly commend Mr Duncan Harriss, Consultant Urologist, as a medicolegal expert on issues relating to urology.  His reports are thorough and well considered and are written in language which is accessible to the lay reader.

“In conference Mr Harriss has an easy understanding of the issues and is of considerable assistance to both his instructing solicitors and Counsel.

“Mr Harriss gives evidence in Court in a competent and straightforward manner which a Court is likely to find helpful in deciding issues which require expert evidence in Mr Harriss’ field.”

Jobling Gowler Solicitors

“Mr Harriss was instructed by solicitors acting on behalf of the Defendant Trust.

“The alleged negligence involved a lady who was admitted to hospital with symptoms of chronic interstitial cystitis.  The Defendant was said to have caused recurrent bowel perforations requiring repeated surgery and prolonged hospitalisation during which the Claimant was affected by MRSA.  Damages were sought in respect of significant pain, discomfort and recognised psychological damage.

“Mr Harriss was instructed to prepare a report on behalf of the Defendant Trust.  Mr Harriss’ first report was clear, thorough and addressed each of the allegations of negligence as set out within the Particulars of Claim.  The report was prepared within an agreed timescale and for a reasonable fee given the potential complexity of this claim.  From the outset, Mr Harriss disagreed with the Claimant’s expert as to the most likely cause of the jejunal perforations. Mr Harriss believed that the most likely explanation was spontaneous perforation and gave thorough explanations as to why he disagreed with each of the potential causes as suggested by the Claimant’s expert.  At the joint meeting of the experts, Mr Harriss did not waver and remained diametrically opposed to the Claimant’s expert evidence upon which the allegations were based.

“The two clinicians involved in the Claimant’s care whose conduct were criticised were fully supportive of the opinions as expressed in Mr Harriss’ report and gave detailed witness evidence which strengthened further the Trust’s Defence.

“A Conference with Counsel followed at which Counsel was satisfied that the Defendant held sufficient evidence to discharge the evidential burden of establishing a feasible non-negligent cause of the perforations. The Defendant prepared for Trial.  The Claimant subsequently discontinued her claim with no order as to costs.

“The Trust was delighted with the outcome of this case. The clear, thorough and unwavering opinion of Mr Harriss from the outset and throughout played a crucial part in the successful outcome of this claim.”

Hill Dickinson Solicitors

“Upon reading your report the Claimant commented to us that it has brought closure to his late father’s death.  He felt that your report provided answers and clarification as to why his late father died of the complications and he was relieved in a sense to hear your explanations”

Cordner Lewis Solicitors

“I would like to take this opportunity to thank you for your assistance throughout, which has been invaluable.  Your report enabled us to maintain arguments with regards to causation which resulted in an excellent outcome for our client.”

Browne Jacobson Solicitors

“I would like to thank you for assisting with my investigation.  Your report was very clear and was useful to the Court in outlining the important issues related to the urological concerns in this case.  It has now come to a close with the criminal proceedings with a final decision of “No Further Action” which is a huge relief to the doctor in question and has saved the Court in time and financial expense.  I am glad I approached you.”

Norfolk CID police departartment